home / stock / nvs / nvs news

NVS News and Press, Novartis AG From 05/03/24

Stock Information
Company Name: Novartis AG
Stock Symbol: NVS
Market: NYSE
Website: novartis.com
Menu
NVS NVS Quote NVS Short NVS News NVS Articles NVS Message Board
Get NVS Alerts

News, Short Squeeze, Breakout and More Instantly...
NVS - 10 Sleep-Well-At-Night Dividend Aristocrats Perfect For Whatever's Coming Next

2024-05-03 07:00:00 ET Summary The stock market is unpredictable, and even professionals struggle to understand it. Stocks have historically been the best-performing asset, but short-term returns are influenced by sentiment, momentum, and luck. According to JPMorgan, 96% of st...
NVS - Radiopharma stocks higher as sector welcomes the latest M&A deal

2024-05-02 14:31:50 ET More on Novartis, Novartis AG, etc. Novartis AG (NVS) Q1 2024 Earnings Call Transcript Novartis: Strong Start To The Year With Beat-And-Raise First Quarter Results Novartis AG 2024 Q1 - Results - Earnings Call Presentation Novartis to b...

NVS - Novartis to buy Mariana Oncology for $1B upfront

2024-05-02 07:46:21 ET Novartis ( NYSE: NVS ) has agreed to acquire cancer drugmaker Mariana Oncology for an upfront payment of $1B and an additional $750M in milestone payments.... Read the full article on Seeking Alpha For further details see: Novartis to buy Maria...

NVS - Novo, Teva, AstraZeneca issued FTC warnings over 'bogus' patents

2024-04-30 12:18:17 ET More on AstraZeneca, GSK, etc. AstraZeneca: A Triple Shot Of Income, Growth, And Value Novo Nordisk: Medicare Coverage To Unlock Another Big Market For Wegovy AstraZeneca: Strong In A Weak Market GSK Q1 2024 Earnings Preview Ast...
NVS - Amgen court hearing in patent lawsuit vs Sandoz over generic Prolia cancelled (update)

2024-04-30 11:23:00 ET More on Amgen Amgen: I Prefer To Chase Value And Dividends Amgen: The Giant With An Impressive Pipeline Move Over Eli Lilly: Amgen Could Be The Next Obesity Wonder Stock Amgen’s Blincyto data send Cullinan higher AbbVie k...

NVS - Terns Pharmaceuticals releases promising phase 1 data on leukemia candidate

2024-04-29 16:31:44 ET More on Terns Pharmaceuticals Terns Pharmaceuticals appoints Melita Sun Jung as chief business officer Terns to report Phase 1 data on GLP-1 drug in 2H 2024 Seeking Alpha’s Quant Rating on Terns Pharmaceuticals Historical earning...

NVS - Amgen court hearing in patent lawsuit vs Sandoz over generic Prolia cancelled

2024-04-29 12:47:40 ET More on Amgen Amgen: I Prefer To Chase Value And Dividends Amgen: The Giant With An Impressive Pipeline Move Over Eli Lilly: Amgen Could Be The Next Obesity Wonder Stock Amgen’s Blincyto data send Cullinan higher AbbVie k...
NVS - New safety risk for MorphoSys drug could complicate Novartis deal - STAT

2024-04-28 20:52:48 ET More on MorphoSys MorphoSys AG (MOR) Q4 2023 Earnings Call Transcript Novartis And MorphoSys Are A Perfect Match Novartis commences tender offer for MorphoSys MorphoSys gains after gaining U.S. antitrust approval for sale to Novartis ...

NVS - J&J, Roche, AstraZeneca poised to have highest orphan drug sales by end of decade

2024-04-28 13:00:22 ET Orphan drugs -- medicines to treat rare diseases -- from Johnson & Johnson ( NYSE: JNJ ), Roche ( OTCQX:RHHBY ), and AstraZeneca ( NASDAQ: AZN ) will allow these companies to reign as the top 3 orphan drugmakers, by sales, in 2028.... Rea...

NVS - Amgen's Blincyto data send Cullinan higher

2024-04-27 15:39:17 ET More on Amgen, Cullinan Oncology, etc. Amgen: I Prefer To Chase Value And Dividends Amgen: The Giant With An Impressive Pipeline Move Over Eli Lilly: Amgen Could Be The Next Obesity Wonder Stock Cullinan Therapeutics expands into autoim...
Previous 10 Next 10